ROG
Rogers Corporation
NYSEUSDEQUITY
Technology
DELAYED
Strong buy
+86/100
Last price
153.96
▼ 2.64 (1.69%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
155.70
Prev close
156.60
Day high
155.45
Day low
151.83
Volume
200.27K
Market cap
$2.75B
P/E (TTM)
89.51
52W range
75.14 – 169.00
Day trading desk
Gap from prior close
-2.14%
Prior close 159.10
VWAP
153.86
+0.06% from price
Relative volume
0.81×
Normal
Session range
2.55%
151.83 – 155.70
Position in range
55%
Mid range
ATR (14D)
6.90
4.48% of price
Prior day high
161.36
PDH
Prior day low
158.91
PDL
Bid / ask spread
—
Quote not published
Session volume
195.64K
Avg 242.84K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+13.34%
+11.4%
1M
+22.52%
+21.4%
3M
+15.65%
+11.1%
6M
+45.69%
+27.5%
YTD
+71.02%
+56.8%
1Y
+88.52%
+72.1%
3Y
+19.11%
-63.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ROG open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+34.44K
Net buying
Buy transactions
10
37.66K shares
Sell transactions
2
3.23K shares
Net transactions
+12
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
216.38K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 19, 26 | EL-HAJ ALI OMAR Chief Executive Officer |
STOCK | 24.82K | $0 | Direct |
| May 6, 26 | LAUZON ARMAND F JR Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | COPE BRETT ALAN Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | FAUST MEGAN Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | MOH WOON KEAT Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | BERGER LARRY L Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | STARKLOFF ERIC HOWARD Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | ROBY ANNE K. Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | OWENS JEFFREY J Director |
STOCK | 1.43K | $0 | Direct |
| May 6, 26 | COSTELLO DONNA M Director |
STOCK | 1.43K | $0 | Direct |
| May 1, 26 | LARABEE BRIAN KEITH Officer |
SELL | 830 | $112.81K | Direct |
| Apr 30, 26 | WALLACE PETER C Director |
SELL | 2.40K | $316.88K | Direct |
| Mar 2, 26 | WEBB MICHAEL REED Officer |
SELL | 954 | $106.19K | Direct |
| Feb 20, 26 | WEBB MICHAEL REED Officer |
SELL | 673 | $72.20K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Fundamentals
Market cap$2.75B
Enterprise value$2.57B
Revenue (TTM)$834.80M
Gross profit$270.80M
EBITDA$128.80M
Net income$31.30M
EPS (TTM)$1.72
Free cash flow$99.83M
Total cash$211.40M
Total debt$28.50M
Book value / share$67.30
Shares outstanding17.87M
Float16.79M
Short % of float4.93%
Dividend yield0.00%
Beta (5Y)0.43
Valuation & profitability ratios
Trailing P/E89.51
Forward P/E33.84
PEG ratio0.52
Price / sales—
Price / book2.29
EV / revenue3.08
EV / EBITDA19.94
Gross margin32.44%
Operating margin9.55%
Profit margin3.75%
Return on equity2.60%
Return on assets3.24%
Debt / equity2.37
Current ratio3.99
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $810.80M | $830.10M | $908.40M | $971.20M | -2.3% |
| Operating revenue | $810.80M | $830.10M | $908.40M | $971.20M | -2.3% |
| Cost of revenue | $554.00M | $553.00M | $601.30M | $650.20M | +0.2% |
| Gross profit | $256.80M | $277.10M | $307.10M | $321.00M | -7.3% |
| Research & development | $28.10M | $34.60M | $35.70M | $35.20M | -18.8% |
| Selling, general & admin | $176.60M | $193.40M | $202.30M | $218.80M | -8.7% |
| Total operating expense | $204.70M | $228.00M | $238.00M | $254.00M | -10.2% |
| Operating income | $52.10M | $49.10M | $69.10M | $67.00M | +6.1% |
| Net interest income | $800.00K | -$800.00K | -$10.10M | -$9.50M | +200.0% |
| Pre-tax income | -$45.10M | $34.30M | $76.30M | $140.40M | -231.5% |
| Tax provision | $16.70M | $8.20M | $19.70M | $23.80M | +103.7% |
| Net income | -$61.80M | $26.10M | $56.60M | $116.60M | -336.8% |
| Net income to common | -$61.80M | $26.10M | $56.60M | $116.60M | -336.8% |
| Basic EPS | -3.40 | 1.40 | 3.04 | 6.21 | -342.9% |
| Diluted EPS | -3.40 | 1.40 | 3.03 | 6.15 | -342.9% |
| EBIT | -$43.90M | $35.90M | $86.70M | $149.90M | -222.3% |
| EBITDA | $10.40M | $85.30M | $137.80M | $195.80M | -87.8% |
| Basic shares | 18.20M | 18.60M | 18.60M | 18.78M | -2.2% |
| Diluted shares | 18.20M | 18.60M | 18.70M | 18.95M | -2.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $197.00M | $159.80M | $131.70M | $235.90M | — | +23.3% |
| Cash & short-term investments | $197.00M | $159.80M | $131.70M | $235.90M | — | +23.3% |
| Accounts receivable | $119.90M | $123.60M | $161.90M | $177.40M | — | -3.0% |
| Inventory | $125.00M | $142.30M | $153.50M | $182.40M | — | -12.2% |
| Total current assets | $500.00M | $493.90M | $526.90M | $659.90M | — | +1.2% |
| Property, plant & equipment | $391.60M | $389.20M | $385.20M | $371.40M | — | +0.6% |
| Goodwill & intangibles | $402.70M | $467.90M | $483.70M | $486.10M | — | -13.9% |
| Total assets | $1.43B | $1.48B | $1.52B | $1.65B | — | -3.5% |
| Total current liabilities | $126.10M | $123.50M | $116.40M | $142.50M | — | +2.1% |
| Long-term debt | — | — | $30.00M | $215.00M | $190.00M | — |
| Total debt | $21.80M | $24.60M | $48.90M | $228.50M | — | -11.4% |
| Total liabilities | $234.20M | $229.50M | $258.20M | $473.70M | — | +2.0% |
| Retained earnings | $1.12B | $1.18B | $1.16B | $1.10B | — | -5.2% |
| Shareholder equity | $1.20B | $1.25B | $1.26B | $1.17B | — | -4.5% |
| Working capital | $373.90M | $370.40M | $410.50M | $517.40M | — | +0.9% |
| Net tangible assets | $793.00M | $783.70M | $775.30M | $686.40M | — | +1.2% |
| Shares issued | 17.80M | 18.50M | 18.62M | 18.57M | — | -3.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$61.80M | $26.10M | $56.60M | $116.60M | -336.8% |
| Depreciation & amortisation | $54.30M | $49.40M | $51.10M | $45.90M | +9.9% |
| Stock-based compensation | $10.90M | $15.10M | $14.30M | $11.80M | -27.8% |
| Change in working capital | $31.00M | $45.80M | -$12.40M | -$91.70M | -32.3% |
| Operating cash flow | $101.20M | $127.10M | $131.40M | $129.50M | -20.4% |
| Capital expenditure | -$30.10M | -$56.10M | -$57.00M | -$116.80M | +46.3% |
| Investing cash flow | -$14.80M | -$45.60M | -$47.90M | -$113.10M | +67.5% |
| Share buybacks | -$52.40M | -$19.80M | $0 | -$25.00M | -164.6% |
| Financing cash flow | -$53.90M | -$50.10M | -$190.30M | -$10.10M | -7.6% |
| Free cash flow | $71.10M | $71.00M | $74.40M | $12.70M | +0.1% |
| End cash position | $197.00M | $159.80M | $131.70M | $235.90M | +23.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $216.80M | $200.50M | $201.50M | $216.00M | $202.80M | +8.1% |
| Operating revenue | $216.80M | $200.50M | $201.50M | $216.00M | $202.80M | +8.1% |
| Cost of revenue | $146.40M | $135.90M | $138.00M | $143.70M | $138.80M | +7.7% |
| Gross profit | $70.40M | $64.60M | $63.50M | $72.30M | $64.00M | +9.0% |
| Research & development | $7.30M | $6.70M | $6.60M | $7.40M | $7.00M | +9.0% |
| Selling, general & admin | $42.20M | $41.20M | $42.00M | $41.60M | $48.50M | +2.4% |
| Total operating expense | $49.70M | $48.00M | $48.40M | $49.50M | $55.40M | +3.5% |
| Operating income | $20.70M | $16.60M | $15.10M | $22.80M | $8.60M | +24.7% |
| Net interest income | $300.00K | $300.00K | -$100.00K | $200.00K | $400.00K | 0.0% |
| Pre-tax income | $21.40M | $11.30M | $9.50M | $16.30M | -$69.30M | +89.4% |
| Tax provision | $7.80M | $6.80M | $4.90M | $7.70M | $4.30M | +14.7% |
| Net income | $13.60M | $4.50M | $4.60M | $8.60M | -$73.60M | +202.2% |
| Net income to common | $13.60M | $4.50M | $4.60M | $8.60M | -$73.60M | +202.2% |
| Basic EPS | 0.76 | 0.25 | 0.26 | 0.48 | -4.00 | +204.0% |
| Diluted EPS | 0.76 | 0.25 | 0.26 | 0.48 | -4.00 | +204.0% |
| EBIT | $21.90M | $11.70M | $9.70M | $16.60M | -$69.00M | +87.2% |
| EBITDA | $35.10M | $25.10M | $24.30M | $29.80M | -$55.10M | +39.8% |
| Basic shares | 17.90M | 17.80M | 17.90M | 18.10M | 18.40M | +0.6% |
| Diluted shares | 18.00M | 17.90M | 18.00M | 18.10M | 18.40M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $181.40M | $195.80M | $197.00M | $167.80M | $157.20M | -7.4% |
| Cash & short-term investments | $211.40M | $195.80M | $197.00M | $167.80M | $157.20M | +8.0% |
| Accounts receivable | $141.40M | $130.40M | $119.90M | $134.20M | $130.10M | +8.4% |
| Inventory | $130.00M | $127.50M | $125.00M | $142.90M | $151.20M | +2.0% |
| Total current assets | $543.60M | $511.40M | $500.00M | $505.00M | $500.10M | +6.3% |
| Property, plant & equipment | $375.90M | $382.40M | $391.60M | $400.70M | $405.50M | -1.7% |
| Goodwill & intangibles | $394.30M | $397.00M | $402.70M | $405.60M | $411.70M | -0.7% |
| Total assets | $1.45B | $1.43B | $1.43B | $1.45B | $1.45B | +1.4% |
| Total current liabilities | $136.30M | $127.30M | $126.10M | $130.00M | $131.90M | +7.1% |
| Total debt | $20.60M | $21.50M | $21.80M | $23.00M | $23.70M | -4.2% |
| Total liabilities | $241.70M | $233.80M | $234.20M | $243.30M | $244.60M | +3.4% |
| Retained earnings | $1.14B | $1.12B | $1.12B | $1.11B | $1.11B | +1.2% |
| Shareholder equity | $1.20B | $1.19B | $1.20B | $1.20B | $1.21B | +1.0% |
| Working capital | $407.30M | $384.10M | $373.90M | $375.00M | $368.20M | +6.0% |
| Net tangible assets | $810.40M | $795.70M | $793.00M | $797.10M | $795.00M | +1.8% |
| Shares issued | 17.90M | 17.84M | 17.80M | 17.90M | 18.10M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $13.60M | $4.50M | $4.60M | $8.60M | -$73.60M | — | +202.2% |
| Depreciation & amortisation | $13.20M | $13.40M | $14.60M | $13.20M | $13.90M | — | -1.5% |
| Stock-based compensation | $2.60M | $1.70M | $2.20M | $800.00K | $4.30M | — | +52.9% |
| Change in working capital | -$7.90M | -$13.20M | $26.50M | $7.10M | -$4.10M | — | +40.2% |
| Operating cash flow | $24.40M | $5.80M | $46.90M | $28.90M | $13.70M | — | +320.7% |
| Capital expenditure | -$6.10M | -$4.70M | -$4.70M | -$7.70M | -$8.10M | — | -29.8% |
| Investing cash flow | -$35.80M | -$4.50M | -$3.60M | -$7.80M | -$7.30M | — | -695.6% |
| Share buybacks | — | — | -$14.30M | -$10.00M | -$28.10M | $0 | — |
| Financing cash flow | -$3.00M | -$1.60M | -$13.90M | -$10.40M | -$28.00M | — | -87.5% |
| Free cash flow | $18.30M | $1.10M | $42.20M | $21.20M | $5.60M | — | +1,563.6% |
| End cash position | $181.40M | $195.80M | $197.00M | $167.80M | $157.20M | — | -7.4% |
Options analytics
Put / call volume
0.21
Call-heavy session
Put / call open interest
0.26
Positioning, not flow
Max pain
140.00
-9.1% from spot
ATM implied vol
67.3%
Nearest strike to spot
Skew (10% OTM)
+1.0%
Puts bid over calls
Call volume
58
Contracts, this expiry
Put volume
12
Contracts, this expiry
Heaviest call OI
165.00
54 contracts
Heaviest put OI
165.00
11 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.99 | 0.92 | -6.8% |
| Mar 2026 | 0.68 | 0.75 | +9.8% |
| Dec 2025 | 0.60 | 0.89 | +48.3% |
| Sep 2025 | 0.69 | 0.90 | +29.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.19 | 3 | $238.00M | +10.2% |
| Next quarter | 0.90 | 3 | $218.93M | +8.6% |
| Current year | 3.77 | 3 | $872.47M | +7.6% |
| Next year | 4.55 | 3 | $945.03M | +8.3% |
Analyst targets & ownership
Mean target$193.33
High target$225.00
Low target$170.00
Implied upside25.57%
Analyst count3
ConsensusSTRONG BUY
Strong buy / Buy1 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders1.21%
Held by institutions102.57%
Institutions holding421
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
147.27
+4.54% from price
SMA 20
139.59
+12.19% from price
SMA 50
133.29
+17.49% from price
SMA 100
138.81
+10.91% from price
SMA 200
123.83
+26.46% from price
EMA 12
147.50
+4.38% from price
EMA 26
140.68
+9.44% from price
EMA 50
137.39
+12.06% from price
RSI (14)
69.7
Neutral
MACD (12,26,9)
6.82
Hist 2.70
ATR (14)
6.90
4.41% of price
Realised vol 30D
41.9%
Annualised
Bollinger upper
160.72
20, 2σ
Bollinger lower
118.46
20, 2σ
50 / 200 cross
Golden
133.29 vs 123.83
Trend bias
Above 200
+26.46%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.37
More volatile than market
Correlation to SPY
0.42
Loosely linked
Realised vol 30D
41.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.1%
Peak to trough
Max drawdown 5Y
-80.8%
Peak to trough
ATR 14
6.90
4.41% of price
Beta (reported)
0.43
5Y monthly, from filing
Short interest
Shares short
629.01K
Prior 607.24K
Change vs prior
+3.6%
Shorts adding
% of float
4.93%
Normal
% of shares out
3.52%
Against total outstanding
Days to cover
3.5
Liquid
Float
16.79M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Oct 1, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Jun 15, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Feb 18, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Apr 30, 25 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Mar 31, 25 | CL King | INITIATED | — | Buy |
| Mar 31, 23 | B. Riley Securities | MAINTAINED | — | Buy |
| Dec 14, 21 | CJS Securities | DOWNGRADE | Market Outperform | Market Perform |
| Nov 4, 21 | Stifel | DOWNGRADE | Buy | Hold |
| Nov 4, 21 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Nov 3, 21 | Wolfe Research | DOWNGRADE | Outperform | Peer Perform |
| Jul 30, 21 | Canaccord Genuity | MAINTAINED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield0.53%
Payout ratio0.00%
Ex-dividend dateJan 9, 1992
Next pay date—
Last split2:1
Split dateMay 30, 2000
SEC filings
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-28
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-19
Offering Registrations
S-8 · 2026-05-07
Periodic Financial Reports
10-Q · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-28
Proxy Statements
DEFA14A · 2026-03-25
Headlines
Rogers Targets $1.5B Sales by 2030 on AI Data Center, Battery Growth
MarketBeat · 5d ago
B. Riley Raises Price Target on Rogers to $225 From $200, Keeps Buy Rating
MT Newswires · 7d ago
Rogers Corp. (ROG) Moves 10.7% Higher: Will This Strength Last?
Zacks · 7d ago
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
GlobeNewswire · 7d ago
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
GlobeNewswire · 7d ago
Rogers Stock Surges 11% After Investor Day. Here’s Why
TIKR · 7d ago
Rogers (ROG) Shares Skyrocket, What You Need To Know
StockStory · 7d ago
Rogers Discloses 2030 Financial Targets
MT Newswires · 7d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.